• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
MKL
Click for more information
0.00% 5.3¢

MIGHTY KINGDOM LIMITED - Corporate Spotlight

Market Cap $11.45M  ! watchlist Created with Sketch. Add to my watchlist
Communication Services

Mighty Kingdom Limited is an Australia-based independent game developer. The Company is... Mighty Kingdom Limited is an Australia-based independent game developer. The Company is engaged in developing a portfolio of video games for consoles, personal computers (PC) and mobile platforms. The Company has business activities in one area, which is video games development. Mobile games and apps developed and/or published by the Company are made available for customers on different app stores, including Apple’s App Store, Google’s Google Play and Valve’s Steam Store. The Company monetizes its games and apps through in-app purchases and advertising offered to the consumers within games and apps for smartphones and tablets. It has released over 50 games, which includes Shopkins, LEGO Friends: Heartlake Rush, Gabby’s Dollhouse, Wild Life and Ava’s Manor, among others. The Company’s wholly owned subsidiaries include Mighty Kingdom Games Pty Ltd, Mighty Kingdom Services Pty Ltd, Mighty Kingdom IP Pty Ltd and Rise Games Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

No Corporate Spotlight currently available.

(20min delay)
Last
5.3¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.45M
Open High Low Value Volume
5.3¢ 5.3¢ 5.3¢ $195 3.678K

Buyers (Bids)

No. Vol. Price($)
1 39543 5.3¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 16248 1
View Market Depth
Last trade - 10.04am 01/10/2024 (20 minute delay) ?
MKL (ASX) Chart

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.